PEHA Stock Overview
PT Phapros, Tbk, together with its subsidiaries, operates in the pharmaceutical and health care industry in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
PT Phapros, Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp496.00 |
| 52 Week High | Rp1,000.00 |
| 52 Week Low | Rp484.00 |
| Beta | 0.39 |
| 1 Month Change | -21.89% |
| 3 Month Change | -9.82% |
| 1 Year Change | -26.52% |
| 3 Year Change | -60.16% |
| 5 Year Change | -77.56% |
| Change since IPO | -72.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| PEHA | ID Pharmaceuticals | ID Market | |
|---|---|---|---|
| 7D | -1.8% | -5.4% | -1.4% |
| 1Y | -26.5% | -26.0% | 2.2% |
Return vs Industry: PEHA matched the ID Pharmaceuticals industry which returned -26% over the past year.
Return vs Market: PEHA underperformed the ID Market which returned 2.2% over the past year.
Price Volatility
| PEHA volatility | |
|---|---|
| PEHA Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in ID Market | 12.0% |
| 10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: PEHA's share price has been volatile over the past 3 months.
Volatility Over Time: PEHA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of ID stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 1,474 | David E. Sidjabat | www.phapros.co.id |
PT Phapros, Tbk, together with its subsidiaries, operates in the pharmaceutical and health care industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing; and Toll-in Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others.
PT Phapros, Tbk Fundamentals Summary
| PEHA fundamental statistics | |
|---|---|
| Market cap | Rp416.64b |
| Earnings (TTM) | Rp5.96b |
| Revenue (TTM) | Rp1.01t |
69.9x
P/E Ratio0.4x
P/S RatioIs PEHA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PEHA income statement (TTM) | |
|---|---|
| Revenue | Rp1.01t |
| Cost of Revenue | Rp514.36b |
| Gross Profit | Rp499.77b |
| Other Expenses | Rp493.81b |
| Earnings | Rp5.96b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.09 |
| Gross Margin | 49.28% |
| Net Profit Margin | 0.59% |
| Debt/Equity Ratio | 102.5% |
How did PEHA perform over the long term?
See historical performance and comparison